Physician profile
Robert D Warren
NPI 1831149681
$4,464.57
in general payments reported to CMS, 2019-2025
13 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,740 · 2022: $92.65 · 2023: $149 · 2024: $299 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $631.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $2,674.50 | 2019-2024 | |
| Pylant Medical | $1,146.46 | 2019-2025 | |
| Nevro Corp. | $244.84 | 2024 | Senza |
| Amgen INC. | $71.70 | 2025 | Krystexxa |
| Stryker Corporation | $69.72 | 2022-2025 | Augment Injectable |
| Horizon Therapeutics Plc | $52.56 | 2022-2023 | Krystexxa |
| Bioventus LLC | $47.28 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Solventum Corporation | $39.63 | 2024-2025 | Activ.A.C. |
| Paratek Pharmaceuticals, INC. | $31.44 | 2023-2024 | Nuzyra |
| Kowa Pharmaceuticals America, INC. | $29.68 | 2023 | Seglentis |
| Ibsa Pharma INC. | $20.18 | 2023 | Tirosint, Licart |
| Kci USA, INC. | $19.99 | 2023 | Activ.A.C. |
| Orthofix Medical, INC. | $16.59 | 2023 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Warren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.